Clinical Trials
9 trialsNCT05165069 2026-02-02
The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3 Active not recruiting
NCT05327751 2022-04-14
HFS
Tanta University
Phase 3 Unknown
NCT03612011 2019-09-06
OCRP
Quanta Medical
Phase 3 Completed
NCT02794493 2019-07-25
Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer
China-Japan Friendship Hospital
Phase 3 Completed
NCT00992706 2019-05-15
F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer
Swiss Cancer Institute
Phase 3 Completed
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT00305643 2015-12-24
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00486213 2015-09-24
Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer
National Cancer Centre, Singapore
Phase 3 Terminated
NCT00559858 2013-08-02
Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown